Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Indena SpA

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

TIRBANIBULIN

NDC Package Code : 17359-4250

Start Marketing Date : 2023-09-21

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

Looking for 897016-82-9 / Tirbanibulin API manufacturers, exporters & distributors?

Tirbanibulin manufacturers, exporters & distributors 1

46

PharmaCompass offers a list of Tirbanibulin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tirbanibulin manufacturer or Tirbanibulin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tirbanibulin manufacturer or Tirbanibulin supplier.

PharmaCompass also assists you with knowing the Tirbanibulin API Price utilized in the formulation of products. Tirbanibulin API Price is not always fixed or binding as the Tirbanibulin Price is obtained through a variety of data sources. The Tirbanibulin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Tirbanibulin

Synonyms

Kx2-391, 897016-82-9, Kx-01, Klisyri, Kx-2-391, Kx-2391

Cas Number

897016-82-9

Unique Ingredient Identifier (UNII)

4V9848RS5G

About Tirbanibulin

Tirbanibulin is an orally bioavailable small molecule Src kinase inhibitor with potential antineoplastic activity. Unlike other Src kinase inhibitors which bind to the ATP-binding site, tirbanibulin specifically binds to the peptide substrate binding site of Src kinase; inhibition of kinase activity may result in the inhibition of primary tumor growth and the suppression of metastasis. Src tyrosine kinases are upregulated in many tumor cells and play important roles in tumor cell proliferation and metastasis.

Tirbanibulin Manufacturers

A Tirbanibulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tirbanibulin, including repackagers and relabelers. The FDA regulates Tirbanibulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tirbanibulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tirbanibulin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tirbanibulin Suppliers

A Tirbanibulin supplier is an individual or a company that provides Tirbanibulin active pharmaceutical ingredient (API) or Tirbanibulin finished formulations upon request. The Tirbanibulin suppliers may include Tirbanibulin API manufacturers, exporters, distributors and traders.

click here to find a list of Tirbanibulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tirbanibulin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tirbanibulin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Tirbanibulin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Tirbanibulin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Tirbanibulin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tirbanibulin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Tirbanibulin suppliers with NDC on PharmaCompass.

Tirbanibulin Manufacturers | Traders | Suppliers

Tirbanibulin Manufacturers, Traders, Suppliers 1
42

We have 1 companies offering Tirbanibulin

Get in contact with the supplier of your choice:

  1. Indena
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.